Top

Published in:

01-03-2014 | Review Article

Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management

Authors: Agustin Cristiano, Agustin Dietrich, Juan Carlos Spina, Victoria Ardiles, Eduardo de Santibañes

Published in: Updates in Surgery | Issue 1/2014

Abstract

Benign liver tumors are common lesions that can be classified into cystic and solid lesions. Cystic lesions are the most frequent; however, they rarely represent a diagnostic or therapeutic challenge. In contrast, solid lesions are more difficult to characterize and management remains controversial. The wide availability and use of advanced imaging modalities, including ultrasonography, computed tomography, and magnetic resonance imaging have led to increased identification of incidental liver masses. Although some of these incidentally discovered masses are malignant, most are benign and must be included in the differential diagnosis. In this article we review FNH and HA. Its etiology, biological behavior, diagnosis, and treatment will be highlighted.

Karhunen PJ (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39(2):183–188 PMID: 3950039 PMCID: 499674PubMed

Ishak KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59(4):995–1013PubMed

Heiken JP (2007) Distinguishing benign from malignant liver tumours. Cancer Imaging 7 Spec No A: S1–S14. doi:10.1102/1470-7330.2007.9084

Buell JF, Tranchart H, Cannon R, Dagher I (2010) Management of benign hepatic tumors. Surg Clin North Am 90(4):719–735. doi:10.1016/j.suc.2010.04.006 PubMed

Maillette de Buy Wenniger L, Terpstra V, Beuers U (2010) Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg 27(1):24–31. doi:10.1159/000268404 PubMed

Bioulac-Sage P, Cubel G, Balabaud C, Zucman-Rossi J (2011) Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 31(1):91–103. doi:10.1055/s-0031-1272837 PubMed

Wanless IR, Mawdsley C, Adams R (1985) On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5(6):1194–1200 (PMID: 4065824 pii: S0270913985001525)PubMed

Vilgrain V, Uzan F, Brancatelli G, Federle MP, Zappa M, Menu Y (2003) Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis. Radiology 229(1):75–79. doi:10.1148/radiol.2291021284 PubMed

Kapp N, Curtis KM (2009) Hormonal contraceptive use among women with liver tumors: a systematic review. Contraception 80(4):387–390. doi:10.1016/j.contraception.2009.01.021 PubMed

10.

Wanless IR, Albrecht S, Bilbao J, Frei JV, Heathcote EJ, Roberts EA, Chiasson D (1989) Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol 2(5):456–462 PMID: 2813344PubMed

11.

Rebouissou S, Bioulac-Sage P, Zucman-Rossi J (2008) Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48(1):163–170. doi:10.1016/j.jhep.2007.10.003 PubMed

12.

Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP (2006) Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 131(5):1561–1572. doi:10.1053/j.gastro.2006.08.042 PubMed

13.

Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, Bioulac-Sage P, Zucman-Rossi J (2008) The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 49(1):61–71. doi:10.1016/j.jhep.2008.03.013 PubMed

14.

Chen YJ, Chen PJ, Lee MC, Yeh SH, Hsu MT, Lin CH (2002) Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization. Genes Chromosom Cancer 35(2):138–143. doi:10.1002/gcc.10103 PubMed

15.

Bioulac-Sage P, Laumonier H, Rullier A, Cubel G, Laurent C, Zucman-Rossi J, Balabaud C (2009) Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 29(3):459–465. doi:10.1111/j.1478-3231.2008.01849.x PubMed

16.

Sato Y, Harada K, Ikeda H, Fijii T, Sasaki M, Zen Y, Nakanuma Y (2009) Hepatic stellate cells are activated around central scars of focal nodular hyperplasia of the liver–a potential mechanism of central scar formation. Hum Pathol 40(2):181–188. doi:10.1016/j.humpath.2008.04.024 PubMed

17.

Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23(12):1441–1454 (PMID: 10584697)PubMed

18.

Vilgrain V (2006) Focal nodular hyperplasia. Eur J Radiol 58(2):236–245. doi:10.1016/j.ejrad.2005.11.043 PubMed

19.

Bioulac-Sage P, Rebouissou S, Sa Cunha A, Jeannot E, Lepreux S, Blanc JF, Blanche H, Le Bail B, Saric J, Laurent-Puig P, Balabaud C, Zucman-Rossi J (2005) Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 128(5):1211–1218 (PMID: 15887105 pii: S0016508505001733)PubMed

20.

Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, Meignan M, Fagniez PL, Zafrani ES, Mathieu D, Dhumeaux D (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22(6):1674–1681 (PMID: 7489973 pii: S0270913995004228)PubMed

21.

Uggowitzer MM, Kugler C, Ruppert-Kohlmayr A, Groell R, Raith J, Schreyer H (2000) Current status of diagnostic imaging of focal nodular hyperplasia of the liver. Rofo 172(9):727–738. doi:10.1055/s-2000-7227 PubMed

22.

van den Esschert JW, van Gulik TM, Phoa SS (2010) Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. Dig Surg 27(1):46–55. doi:10.1159/000268407 PubMed

23.

Uggowitzer MM, Kugler C, Mischinger HJ, Groll R, Ruppert-Kohlmayr A, Preidler KW, Quehenberger F (1999) Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med 18(7):445–451 (quiz 453–444 [PMID: 10400046])PubMed

24.

Quaia E (2011) The real capabilities of contrast-enhanced ultrasound in the characterization of solid focal liver lesions. Eur Radiol 21(3):457–462. doi:10.1007/s00330-010-2007-0 PubMed

25.

Kim MJ, Lim HK, Kim SH, Choi D, Lee WJ, Lee SJ, Lim JH (2004) Evaluation of hepatic focal nodular hyperplasia with contrast-enhanced gray scale harmonic sonography: initial experience. J Ultrasound Med 23(2):297–305PubMed

26.

Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A (2005) Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 78(932):704–707. doi:10.1259/bjr/88181612 PubMed

27.

Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR (2008) Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR 190(1):58–66. doi:10.2214/AJR.07.2493 PubMed

28.

Trillaud H, Bruel JM, Valette PJ, Vilgrain V, Schmutz G, Oyen R, Jakubowski W, Danes J, Valek V, Greis C (2009) Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 15(30):3748–3756 (PMID: 19673015 PMCID: 2726452)PubMed

29.

Procacci C, Fugazzola C, Cinquino M, Mangiante G, Zonta L, Andreis IA, Nicoli N, Pistolesi GF (1992) Contribution of CT to characterization of focal nodular hyperplasia of the liver. Gastrointest Radiol 17(1):63–73. doi:10.1007/BF01888511 PubMed

30.

Rogers JV, Mack LA, Freeny PC, Johnson ML, Sones PJ (1981) Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy. AJR 137(5):983–990 (PMID: 6975026)PubMed

31.

Brancatelli G, Federle MP, Grazioli L, Blachar A, Peterson MS, Thaete L (2001) Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 219(1):61–68 (PMID: 11274535)PubMed

32.

Carlson SK, Johnson CD, Bender CE, Welch TJ (2000) CT of focal nodular hyperplasia of the liver. AJR 174(3):705–712 (PMID: 10701613)PubMed

33.

Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, de Rave S, Ijzermans JN, de Man RA (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24(1):3–17. doi:10.1148/rg.241035050. (discussion 18–19)PubMed

34.

Blachar A, Federle MP, Ferris JV, Lacomis JM, Waltz JS, Armfield DR, Chu G, Almusa O, Grazioli L, Balzano E, Li W (2002) Radiologists’ performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology 223(2):532–539 (PMID: 11997564)PubMed

35.

Vilgrain V, Flejou JF, Arrive L, Belghiti J, Najmark D, Menu Y, Zins M, Vullierme MP, Nahum H (1992) Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184(3):699–703 (PMID: 1509052)PubMed

36.

Mortele KJ, Praet M, Van Vlierberghe H, de Hemptinne B, Zou K, Ros PR (2002) Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 27(6):700–707. doi:10.1007/s00261-001-0140-6 PubMed

37.

Grazioli L, Morana G, Federle MP, Brancatelli G, Testoni M, Kirchin MA, Menni K, Olivetti L, Nicoli N, Procacci C (2001) Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 221(3):731–739 (PMID: 11719669)PubMed

38.

Chung YE, Park MS, Park YN, Lee HJ, Seok JY, Yu JS, Kim MJ (2009) Hepatocellular carcinoma variants: radiologic-pathologic correlation. AJR 193(1):W7–W13. doi:10.2214/AJR.07.3947 PubMed

39.

Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254(1):47–66. doi:10.1148/radiol.09090021 PubMed

40.

Ba-Ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W (2009) Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 19(2):342–357. doi:10.1007/s00330-008-1172-x PubMed

41.

Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236(1):166–177. doi:10.1148/radiol.2361040338 PubMed

42.

Bonney GK, Gomez D, Al-Mukhtar A, Toogood GJ, Lodge JP, Prasad R (2007) Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB (Oxford) 9(5):368–372. doi:10.1080/13651820701504173

43.

Nahm CB, Ng K, Lockie P, Samra JS, Hugh TJ (2011) Focal nodular hyperplasia—a review of myths and truths. J Gastrointest Surg 15(12):2275–2283. doi:10.1007/s11605-011-1680-x PubMed

44.

Belghiti J, Pateron D, Panis Y, Vilgrain V, Flejou JF, Benhamou JP, Fekete F (1993) Resection of presumed benign liver tumours. Br J Surg 80(3):380–383 (PMID: 8472159)PubMed

45.

Chen MF (2000) Hepatic resection for benign tumours of the liver. J Gastroenterol Hepatol 15(6):587–592 (PMID: 10921410)PubMed

46.

Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E, Franceschi D, Badalamenti S, Jeffers L, Tzakis A, Schiff ER (2001) Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 67(2):173–178 (PMID: 11243545)PubMed

47.

Perrakis A, Demir R, Muller V, Mulsow J, Aydin U, Alibek S, Hohenberger W, Yedibela S (2012) Management of the focal nodular hyperplasia of the liver: evaluation of the surgical treatment comparing with observation only. Am J Surg 204(5):689–696. doi:10.1016/j.amjsurg.2012.02.006 PubMed

48.

Ott R, Hohenberger W (1998) Focal nodular hyperplasia and liver cell adenoma: operation or observation? Zentralbl Chir 123(2):145–153 (PMID: 9556887)PubMed

49.

Baum JK, Bookstein JJ, Holtz F, Klein EW (1973) Possible association between benign hepatomas and oral contraceptives. Lancet 2(7835):926–929 (PMID: 4126557)PubMed

50.

Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242(7):644–648 (PMID: 221698)PubMed

51.

Rosenberg L (1991) The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception 43(6):643–652 (PMID: 1651205)PubMed

52.

Buhler H, Pirovino M, Akobiantz A, Altorfer J, Weitzel M, Maranta E, Schmid M (1982) Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 82(4):775–782 (pii: S0016508582000596, PMID: 6277724)PubMed

53.

Edmondson HA, Reynolds TB, Henderson B, Benton B (1977) Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 86(2):180–182 (PMID: 835939)PubMed

54.

Noels JE, van Aalten SM, van der Windt DJ, Kok NF, de Man RA, Terkivatan T, Ijzermans JN (2011) Management of hepatocellular adenoma during pregnancy. J Hepatol 54(3):553–558. doi:10.1016/j.jhep.2010.07.022 PubMed

55.

Terkivatan T, de Wilt JH, de Man RA, Ijzermans JN (2000) Management of hepatocellular adenoma during pregnancy. Liver 20(2):186–187 (PMID: 10847490)PubMed

56.

Martin NM, Abu Dayyeh BK, Chung RT (2008) Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage. World J Gastroenterol 14(28):4573–4575 (PMID: 18680242 PMCID: 2731289)PubMed

57.

Reddy SK, Kishnani PS, Sullivan JA, Koeberl DD, Desai DM, Skinner MA, Rice HE, Clary BM (2007) Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 47(5):658–663. doi:10.1016/j.jhep.2007.05.012 PubMed

58.

Bioulac-Sage P, Taouji S, Possenti L, Balabaud C (2012) Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int 32(8):1217–1221. doi:10.1111/j.1478-3231.2012.02786.x PubMed

59.

Shaked O, Reddy KR (2009) Approach to a liver mass. Clin Liver Dis 13(2):193–210. doi:10.1016/j.cld.2009.02.004 PubMed

60.

Barthelmes L, Tait IS (2005) Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) 7(3):186–196. doi:10.1080/13651820510028954

61.

Lui AF, Hiratzka LF, Hirose FM (1980) Multiple adenomas of the liver. Cancer 45(5):1001–1004 (PMID: 7260831)PubMed

62.

Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc JF, Cubel G, Trillaud H, Zucman-Rossi J, Balabaud C, Saric J (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50(2):481–489. doi:10.1002/hep.22995 PubMed

63.

Vetelainen R, Erdogan D, de Graaf W, ten Kate F, Jansen PL, Gouma DJ, van Gulik TM (2008) Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 28(4):499–508. doi:10.1111/j.1478-3231.2008.01669.x PubMed

64.

Chiche L, Dao T, Salame E, Galais MP, Bouvard N, Schmutz G, Rousselot P, Bioulac-Sage P, Segol P, Gignoux M (2000) Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 231(1):74–81 (PMID: 10636105 PMCID: 1420968)PubMed

65.

Shanbhogue A, Shah SN, Zaheer A, Prasad SR, Takahashi N, Vikram R (2011) Hepatocellular adenomas: current update on genetics, taxonomy, and management. J Comput Assist Tomogr 35(2):159–166. doi:10.1097/RCT.0b013e31820bad61 PubMed

66.

Rubin RA, Mitchell DG (1996) Evaluation of the solid hepatic mass. Med Clin North Am 80(5):907–928 (PMID: 8804368)PubMed

67.

Jenkins RL, Johnson LB, Lewis WD (1994) Surgical approach to benign liver tumors. Semin Liver Dis 14(2):178–189. doi:10.1055/s-2007-1007310 PubMed

68.

Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A (2001) Hepatic adenomas: imaging and pathologic findings. Radiographics 21(4):877–892 (discussion 892-874, PMID: 11452062)PubMed

69.

Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, Balabaud C, Zucman-Rossi J (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46(3):740–748. doi:10.1002/hep.21743 PubMed

70.

Paradis V, Benzekri A, Dargere D, Bieche I, Laurendeau I, Vilgrain V, Belghiti J, Vidaud M, Degott C, Bedossa P (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126(5):1323–1329 (PMID: 15131793, pii: S0016508504001544)PubMed

71.

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia (2009) Hepatology 49(2): 658–664. doi:10.1002/hep.22709

72.

Lagana SM, Salomao M, Bao F, Moreira RK, Lefkowitch JH, Remotti HE (2012) Utility of an Immunohistochemical Panel Consisting of Glypican-3, Heat-shock Protein-70, and Glutamine Synthetase in the Distinction of Low-grade Hepatocellular Carcinoma From Hepatocellular Adenoma. Appl Immunohistochem Mol Morphol. doi:10.1097/PAI.0b013e31825d527f

73.

Libbrecht L, Severi T, Cassiman D, Van der Borght S, Pirenne J, Nevens F, Verslype C, van Pelt J, Roskams T (2006) Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 30(11):1405–1411. doi:10.1097/01.pas.0000213323.97294.9a PubMed

74.

Nassar A, Cohen C, Siddiqui MT (2009) Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies. Diagn Cytopathol 37(9):629–635. doi:10.1002/dc.21075 PubMed

75.

Shafizadeh N, Kakar S (2011) Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques. Adv Anat Pathol 18(6):438–445. doi:10.1097/PAP.0b013e318234abb4 PubMed

76.

van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, de Man RA, Ijzermans JN (2011) Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol 55(1):120–125. doi:10.1016/j.jhep.2010.10.030 PubMed

77.

Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, IJ JN (2001) Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 136(9):1033–1038 (PMID: 11529826,pii: soa0257)PubMed

78.

Herman P, Pugliese V, Machado MA, Montagnini AL, Salem MZ, Bacchella T, D’Albuquerque LA, Saad WA, Machado MC, Pinotti HW (2000) Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 24(3):372–376. doi:10.1007/s002689910059 PubMed

79.

Charny CK, Jarnagin WR, Schwartz LH, Frommeyer HS, DeMatteo RP, Fong Y, Blumgart LH (2001) Management of 155 patients with benign liver tumours. Br J Surg 88(6):808–813. doi:10.1046/j.0007-1323.2001.01771.x PubMed

80.

Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, Maschek H, Tusch G, Pichlmayr R (1997) Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 21(9):983–990 (discussion 990–981, PMID: 9361515)PubMed

81.

Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PF 2nd (1983) Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 84(5 Pt 1):994–1002 (PMID: 6299876,pii: S0016508583000992)PubMed

82.

Hussain SM, Semelka RC (2005) Hepatic imaging: comparison of modalities. Radiol Clin North Am 43(5):929–947. doi:10.1016/j.rcl.2005.05.006 PubMed

83.

Golli M, Van Nhieu JT, Mathieu D, Zafrani ES, Cherqui D, Dhumeaux D, Vasile N, Rahmouni A (1994) Hepatocellular adenoma: color Doppler US and pathologic correlations. Radiology 190(3):741–744 (PMID: 8115621)PubMed

84.

Ichikawa T, Federle MP, Grazioli L, Nalesnik M (2000) Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214(3):861–868 (PMID: 10715059)PubMed

85.

Hussain SM, van den Bos IC, Dwarkasing RS, Kuiper JW, den Hollander J (2006) Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 16(9):1873–1886. doi:10.1007/s00330-006-0292-4 PubMed

86.

Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME (1994) Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR 163(1):113–116 (PMID: 8010195)PubMed

87.

Arrive L, Flejou JF, Vilgrain V, Belghiti J, Najmark D, Zins M, Menu Y, Tubiana JM, Nahum H (1994) Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193(2):507–512 (PMID: 7972769)PubMed

88.

Chung KY, Mayo-Smith WW, Saini S, Rahmouni A, Golli M, Mathieu D (1995) Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR 165(2):303–308 (PMID: 7618545)PubMed

89.

Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48(3):808–818. doi:10.1002/hep.22417 PubMed

90.

Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR (2011) Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics 31(6):1529–1543. doi:10.1148/rg.316115527 PubMed

91.

Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43(3):515–524. doi:10.1002/hep.21068 PubMed

92.

Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Tilanus HW, IJ JN (2001) Treatment of ruptured hepatocellular adenoma. Br J Surg 88(2):207–209. doi:10.1046/j.1365-2168.2001.01648.x PubMed

93.

Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ (1998) Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 4(5):388–398 (PMID: 9724476, pii: S1527646598000690)PubMed

94.

Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC (1996) Selective management of hepatic adenomas. Am Surg 62(10):825–829PubMed

95.

Edmondson HA, Henderson B, Benton B (1976) Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294(9):470–472. doi:10.1056/NEJM197602262940904 PubMed

96.

Cho SW, Marsh JW, Steel J, Holloway SE, Heckman JT, Ochoa ER, Geller DA, Gamblin TC (2008) Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 15(10):2795–2803. doi:10.1245/s10434-008-0090-0 PubMed

97.

Kent DR, Nissen ED, Nissen SE, Ziehm DJ (1978) Effect of pregnancy on liver tumor associated with oral contraceptives. Obstet Gynecol 51(2):148–151 (PMID: 622225)PubMed

98.

Bioulac-Sage P, Balabaud C, Zucman-Rossi J (2010) Subtype classification of hepatocellular adenoma. Dig Surg 27(1):39–45. doi:10.1159/000268406 PubMed

99.

Perrakis A, Muller V, Oeckl K, Adamietz B, Demir R, Hohenberger W, Yedibela S (2012) Indications and long-term outcome after elective surgery for hepatocellular adenoma. Am Surg 78(1):80–85 (PMID: 22273320)PubMed

100.

Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR, Martin RC, D’Angelica M, Staley CA, Choti MA, Jarnagin WR, Schulick RD, Kooby DA (2009) Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 16(3):640–648. doi:10.1245/s10434-008-0275-6 PubMed

101.

Ribeiro Junior MA, Chaib E, Saad WA, D’Albuquerque LA, Cecconello I (2009) Surgical management of spontaneous ruptured hepatocellular adenoma. Clinics (Sao Paulo) 64(8):775–779. doi:10.1590/S1807-59322009000800011

102.

Flowers BF, McBurney RP, Vera SR (1990) Ruptured hepatic adenoma. A spectrum of presentation and treatment. Am Surg 56(6):380–383 (PMID: 2161632)PubMed

103.

Choi BY, Nguyen MH (2005) The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 39(5):401–412 (PMID: 15815209, pii: 00004836-200505000-00012)PubMed

104.

Cobey FC, Salem RR (2004) A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 187(2):181–191. doi:10.1016/j.amjsurg.2003.11.016 PubMed

105.

Gianopoulos JG (1995) Establishing the criteria for anesthesia and other precautions for surgery during pregnancy. Surg Clin North Am 75(1):33–45 (PMID: 7855716)PubMed

106.

Stain SC, Woodburn DA, Stephens AL, Katz M, Wagner WH, Donovan AJ (1996) Spontaneous hepatic hemorrhage associated with pregnancy. Treatment by hepatic arterial interruption. Ann Surg 224(1):72–78 (PMID: 8678621 PMCID: 1235249)PubMed

107.

Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137(5):1698–1705. doi:10.1053/j.gastro.2009.07.061 PubMed

108.

Marino IR, Scantlebury VP, Bronsther O, Iwatsuki S, Starzl TE (1992) Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia. Transpl Int 5(Suppl 1):S201–S205 (PMID: 14621777 PMCID: 2993572)PubMedCentralPubMed

109.

Reddy SK, Austin SL, Spencer-Manzon M, Koeberl DD, Clary BM, Desai DM, Smith AD, Kishnani PS (2009) Liver transplantation for glycogen storage disease type Ia. J Hepatol 51(3):483–490. doi:10.1016/j.jhep.2009.05.026 PubMed

110.

Matern D, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, Emond J, Haagsma EB, Hug G, Lachaux A, Smit GP, Chen YT (1999) Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 158(Suppl 2):S43–S48 (PMID: 10603098 PMCID: 3006437 pii: 9158S043.431)PubMedCentralPubMed

Title: Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management
Authors: Agustin Cristiano
Agustin Dietrich
Juan Carlos Spina
Victoria Ardiles
Eduardo de Santibañes
Publication date: 01-03-2014
Publisher: Springer Milan
Published in: Updates in Surgery / Issue 1/2014
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-013-0222-3

At a glance: The STEP trials

Springer Medicine

Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Is a policy of watch and wait after a complete response following neoadjuvant treatment for locally advanced rectal adenocarcinoma justified? Should we reset the limit?

Primary hepatic lymphoma in a patient with chronic hepatitis B and C infection: diagnostic pitfalls and therapeutic challenge

The management of esophageal achalasia: from diagnosis to surgical treatment

Schwannoma mimicking a neoplastic thyroid nodule

Cholesterol embolization of right colon, misdiagnosed as colon tumor

Local repair of a trans-stomal ileocecal prolapse by stapler device